Will Tesla Have Profits In Q4?

Will Tesla Have Profits In Q4?

Tesla (NASDAQ:TSLA) took investors by surprise last month when the electric-car company swung from a loss to a meaningful profit. On a non-GAAP basis, Tesla earned $2.90 per share, crushing a consensus analyst estimate for non-GAAP EPS of just $0.17. GAAP earnings and free cash flow for the period were impressive, too. The company’s sudden profitability comes as Model 3 deliveries are surging.

Read more

What’s In Store For Snap’s Future?

What’s In Store For Snap’s Future?

First Snap (NYSE:SNAP) was a vanishing-message social media platform. Then management decided it was a camera company and set its eyes on drones. Now, apparently, it wants to become a video programming channel.

Read more

Should You Invest In Pattern Energy Group Inc.?

Should You Invest In Pattern Energy Group Inc.?

The world needs to invest an estimated $10 trillion in the decades ahead to replace its current carbon-based power systems. The market opportunity is even larger when factoring in energy-demand growth and the electrification of transportation. That positions renewable power companies like Pattern Energy Group (NASDAQ:PEGI) for a massive upside in the coming years.

Read more

Will Netflix Keep It’s Upward Trend?

Will Netflix Keep It’s Upward Trend?

Netflix‘s (NASDAQ:NFLX) third-quarter earnings report is scheduled to be released next week. As usual, one key metric investors will be watching is member growth. Netflix’s net member additions for a given quarter provide insight into how well the company is retaining and attracting members — obviously a key narrative for a company whose entire business model is based on a monthly subscription.

Read more

Is Rite Aid At Its Lowest?

Is Rite Aid At Its Lowest?

Another week, another five-year low for Rite Aid (NYSE:RAD) investors. Shares of the meandering drugstore operator plummeted another 10% last week, but the entire hit came during first two trading days of last week. Rite Aid has closed at exactly $1.15 for four consecutive trading days. It’s a coincidence, sure, but also a sign of potential stability.

Read more

These 2 Biotech Stocks Have Massive Upside

These 2 Biotech Stocks Have Massive Upside

Canada’s Tilray (NASDAQ:TLRY), a marijuana cultivator and distributor, has given early investors the ride of their lives since going public last June. Last week, for instance, the company’s stock peaked at exactly $300 per share, representing a jaw-dropping 856% gain for the brave souls that bought this speculative IPO right off the bat.

Read more

What You Need To Know About The Marijuana Stock Tilray

Marijuana stocks are on fire, and it’s certainly not hard to understand why. Euphoria is exceptionally high (pardon the pun) with Canada set to legalize the sale and consumption of recreational marijuana exactly five weeks from today. A legal weed industry is one that could bring in billions of dollars annually, which is a big reason why investors have pushed marijuana stock valuations into the stratosphere.

Read more

Will Apple Stock Hit $250

Will Apple Stock Hit $250

Shares of Apple (NASDAQ:AAPL) have been surging recently. But one analyst from Canaccord Genuity thinks there’s still more upside ahead for the stock, upgrading his price target for the tech giant to $250. Canaccord Genuity analyst Michael Walkley cited Apple’s overall healthy iPhone business and the upcoming release of new iPhone models as catalysts for the stock.

Read more

Consider These 3 Small-Cap Bank Stocks

Consider These 3 Small-Cap Bank Stocks

The big banks tend to grab most of the headlines, but there are some good reasons to look at the smaller end of the banking spectrum. Not only do smaller banks have more room to grow, but they also have some other advantages, such as lower compliance costs. Three smaller banks three of The Motley Fool’s contributors think are worth a look right now are BofI Holding(NASDAQ:BOFI)Sandy Spring Bancorp (NASDAQ:SASR), and Western Alliance Bancorporation (NYSE:WAL).

Read more

Buy These Healthcare Stocks Now!

Buy These Healthcare Stocks Now!

There’s more to healthcare than just the biotechnology industry, but you’d hardly know that by looking at the leader board this year. The vast majority of the sector’s top performers this year make medicines, but a handful come from different corners of the sector.

Read more